Jazz Pharma (JAZZ) Posts Q2 adj.-EPS of $0.28, Tops Views; Increases FY10 Outlook
Tweet Send to a Friend
Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) reports Q2 adjustd EPS of $0.28, 14 cents better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
